AmplioSpeech Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

AmplioSpeech Inc. - overview

Established

2014

Location

Rockville, MD, US

Primary Industry

Education/Training

About

AmplioSpeech Inc. , based in the US, specializes in enhancing communication through innovative speech therapy solutions, utilizing AI technology to deliver personalized therapy sessions for individuals with speech disorders. AmplioSpeech Inc. provides cloud-based speech therapy solutions for individuals with speech disorders.


Founded in 2014 and headquartered in Rockville, US, the company was established by Ofer Amir, Shirley Shapira, and Yair Shapira. In April 2021, AmplioSpeech raised USD 27. 00 mn in a Series A funding round led by Quad Partners, with participation from Volos Capital, bringing the total amount raised to USD 27. 00 mn.


The company has executed 8 deals as of the latest deal date in 2021. AmplioSpeech specializes in innovative speech therapy solutions designed to enhance communication for individuals with speech disorders. Their primary product offering is a cloud-based platform that leverages artificial intelligence to provide personalized speech therapy exercises. The platform supports various end users, including children with speech delays and adults recovering from speech impairments due to medical conditions.


AmplioSpeech’s services are structured to facilitate easy access for both therapists and patients, allowing for real-time progress tracking and tailored therapy sessions. The company primarily serves clients in North America and Europe, focusing on educational institutions, healthcare facilities, and individual consumers seeking effective speech therapy solutions. AmplioSpeech generates revenue through a subscription-based model, offering various pricing tiers tailored to the needs of educational institutions, healthcare providers, and individual users. Clients can choose from multiple subscription options based on the number of users and the level of access required, ensuring flexibility in the transaction structure.


This approach allows institutions and practitioners to integrate the platform into their existing therapy programs seamlessly. The company’s flagship services are designed to enhance user engagement and outcomes, driving demand across its client base. Additionally, partnerships with schools and therapy centers bolster revenue streams, as these entities may also implement the platform as part of their standard offerings to students and patients. In April 2021, AmplioSpeech Inc.


raised USD 27. 00 mn in venture funding led by Quad Partners, with participation from Volos Capital. The company plans to utilize this funding to enhance product development and expand its marketing, sales, and customer success operations. AmplioSpeech is focused on increasing its footprint in North America and Europe, targeting educational institutions and healthcare facilities as key markets for growth.


Current Investors

Publicis Groupe, Zaitoun Ventures, Israel Innovation Authority

Primary Industry

Education/Training

Sub Industries

Education & Training Website, Education & Training Services, Education & Training Software

Website

www.ampliospeech.com

Verticals

EdTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.